BACKGROUND: Post-translational cleavage of full-length cyclin E from the N-terminus can produce low molecular weight (LMW) isoforms of cyclin E containing the C-terminus only. AIM: To assess their presence in early-onset gastric cancer (EOGC), stump cancers and conventional gastric cancers and ascertain how they influence survival in EOGC. METHODS: The expression of full-length and LMW isoforms of cyclin E in 330 gastric cancers, including early-onset gastric cancer (EOGC), stump cancer and conventional gastric cancer (>45 years old) was compared using antibodies targeted to the N- and C-terminals. RESULTS: LMW isoforms were found in 35% of EOGCs, compared to 8% of conventional gastric cancers and 4% of stump cancers; their presence was visualised in cell lines using western blot analysis. In addition, C-terminal staining was a positive predictor of survival in EOGC. In contrast, no correlation with survival was found with the N-terminal antibody which detects only full-length cyclin E. CONCLUSION: EOGCs have a unique molecular phenotype and LMW isoforms of cyclin E may independently influence survival in EOGC.
BACKGROUND: Post-translational cleavage of full-length cyclin E from the N-terminus can produce low molecular weight (LMW) isoforms of cyclin E containing the C-terminus only. AIM: To assess their presence in early-onset gastric cancer (EOGC), stump cancers and conventional gastric cancers and ascertain how they influence survival in EOGC. METHODS: The expression of full-length and LMW isoforms of cyclin E in 330 gastric cancers, including early-onset gastric cancer (EOGC), stump cancer and conventional gastric cancer (>45 years old) was compared using antibodies targeted to the N- and C-terminals. RESULTS: LMW isoforms were found in 35% of EOGCs, compared to 8% of conventional gastric cancers and 4% of stump cancers; their presence was visualised in cell lines using western blot analysis. In addition, C-terminal staining was a positive predictor of survival in EOGC. In contrast, no correlation with survival was found with the N-terminal antibody which detects only full-length cyclin E. CONCLUSION: EOGCs have a unique molecular phenotype and LMW isoforms of cyclin E may independently influence survival in EOGC.
Authors: Kimberly S Lucenay; Iman Doostan; Cansu Karakas; Tuyen Bui; Zhiyong Ding; Gordon B Mills; Kelly K Hunt; Khandan Keyomarsi Journal: Cancer Res Date: 2016-02-29 Impact factor: 12.701
Authors: Iman Doostan; Cansu Karakas; Mehrnoosh Kohansal; Kwang-Hui Low; Matthew J Ellis; John A Olson; Vera J Suman; Kelly K Hunt; Stacy L Moulder; Khandan Keyomarsi Journal: Clin Cancer Res Date: 2017-09-25 Impact factor: 12.531
Authors: Kelly K Hunt; Khandan Keyomarsi; Cansu Karakas; Min Jin Ha; Anna Biernacka; Min Yi; Aysegul A Sahin; Opoku Adjapong; Gabriel N Hortobagyi; Melissa Bondy; Patricia Thompson; Kwok Leung Cheung; Ian O Ellis; Sarah Bacus; W Fraser Symmans; Kim-Anh Do Journal: Clin Cancer Res Date: 2016-11-23 Impact factor: 12.531
Authors: Mylin A Torres; Uma Raju; David Molkentine; Oliver Riesterer; Luka Milas; K Kian Ang Journal: Invest New Drugs Date: 2010-02-02 Impact factor: 3.850
Authors: Cansu Karakas; Anna Biernacka; Tuyen Bui; Aysegul A Sahin; Min Yi; Said Akli; Jolie Schafer; Angela Alexander; Opoku Adjapong; Kelly K Hunt; Khandan Keyomarsi Journal: Am J Pathol Date: 2016-05-13 Impact factor: 4.307
Authors: R Sitarz; W W J de Leng; M Polak; F H M Morsink; O Bakker; W P Polkowski; R Maciejewski; G J A Offerhaus; A N Milne Journal: Virchows Arch Date: 2008-08-08 Impact factor: 4.064
Authors: Cathy B Moelans; Anya N Milne; Folkert H Morsink; G Johan A Offerhaus; Paul J van Diest Journal: Cell Oncol (Dordr) Date: 2011-03-11 Impact factor: 6.730